Literature DB >> 7790460

Use of a colorimetric system for yeast susceptibility testing.

R N Tiballi1, X He, L T Zarins, S G Revankar, C A Kauffman.   

Abstract

We examined the reliability and accuracy of a colorimetric assay using Alamar Blue reagent in the performance of susceptibility tests for Candida albicans. We compared the broth macrodilution method recommended by the National Committee for Clinical Laboratory Standards (NCCLS) with a macrodilution method modified with the Alamar reagent and a microdilution method modified with the Alamar reagent. The MICs of fluconazole and itraconazole for 97 isolates of C. albicans and 3 control isolates were tested. For fluconazole, the Alamar-modified broth macrodilution method yielded 94% (91 of 97) concordance within 2 dilutions compared with the NCCLS method, while the microdilution method yielded 95% (92 of 97) concordance. With Alamar-modified methods for itraconazole, broth macrodilution yielded 97% (94 of 97) concordance within 2 dilutions. MICs obtained by the microdilution method, although tightly nested, were shifted to a higher value when compared with those obtained by the NCCLS method; there was only 77% (75 of 97) concordance within 2 dilutions but 97% concordance (94 of 97) within 3 dilutions. Tests by all methods with quality control strains showed excellent reproducibilities. For fluconazole, the methods modified with the Alamar reagent yielded clear endpoints and excellent correlation for the broth macrodilution and microdilution methods. For itraconazole, the methods modified with the Alamar reagent yielded clear endpoints and were reproducible, but higher MICs were obtained by the microdilution methods compared with those obtained by the NCCLS methods.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790460      PMCID: PMC228067          DOI: 10.1128/jcm.33.4.915-917.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

2.  Susceptibility of yeast-like fungi to a new antifungal agent, LY 121019.

Authors:  A N Bulo; S F Bradley; C A Kauffman
Journal:  Mycoses       Date:  1988-06       Impact factor: 4.377

Review 3.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 4.  Susceptibility testing of fungi: current status of the standardization process.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.

Authors:  M A Pfaller; C Grant; V Morthland; J Rhine-Chalberg
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

6.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

7.  Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.

Authors:  W E Dismukes; R W Bradsher; G C Cloud; C A Kauffman; S W Chapman; R B George; D A Stevens; W M Girard; M S Saag; C Bowles-Patton
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

8.  Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; A L Barry
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

9.  Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.

Authors:  M A Pfaller; J Rhine-Chalberg; S W Redding; J Smith; G Farinacci; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

10.  Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

Authors:  E Bart-Delabesse; P Boiron; A Carlotti; B Dupont
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

View more
  32 in total

1.  Comparative study of agar diffusion test and the NCCLS macrobroth method for in vitro susceptibility testing of Candida spp.

Authors:  L M Soni; M N Burattini; A C Pignatari; O F Gompertz; A L Colombo
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Fluorometric assessment of In vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power.

Authors:  C N Okeke; R Tsuboi; M Kawai; H Ogawa
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.

Authors:  I Pujol; J Capilla; B Fernández-Torres; M Ortoneda; J Guarro
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.

Authors:  Sandra Romero-Steiner; Willie Spear; Nekeidra Brown; Patricia Holder; Thomas Hennessy; Patricia Gomez De Leon; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

5.  Unacceptable performance and the lack of reproducibility results in the report of colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.

Authors:  Ibrahim C Acuner; Cafer Eroglu
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

6.  Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.

Authors:  Behzad Kasravi; Diana H Lee; Jean W Lee; Stephen Dada; Hobart W Harris
Journal:  J Surg Res       Date:  2007-07-30       Impact factor: 2.192

7.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

9.  Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Karlsson; A Bolmström
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.

Authors:  M A Pfaller; S Arikan; M Lozano-Chiu; Y Chen; S Coffman; S A Messer; R Rennie; C Sand; T Heffner; J H Rex; J Wang; N Yamane
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.